Hellerup, Denmark

Claus Bregengaard

This inventor holds 8 USPTO granted patents. Top assignees: Novo Nordisk A/s, Zymogenetics, Inc., Other. Active years: 1997-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Claus Bregengaard. Retrieved from https://idiyas.com/inventor/claus-bregengaard

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.8

ph-index = 4

Forward Citations = 186(Granted Patents)


Company Filing History:

goldMedal7 out of 1,803 
 
Novo Nordisk A/s
 patents
silverMedal4 out of 723 
 
Zymogenetics, Inc.
 patents
bronzeMedal1 out of 834,570 
Other
 patents
where one patent can have more than one assignee

Years Active: 1997-2001

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Claus Bregengaard - Innovative Danish Inventor

Introduction: Claus Bregengaard is a renowned inventor hailing from Hellerup, Denmark, known for his groundbreaking contributions to various fields.

Latest Patents: Claus Bregengaard holds several patents in the areas of renewable energy technologies, sustainable agriculture, and advanced materials.

Career Highlights: With a career spanning over two decades, Claus Bregengaard has worked with leading research institutions and universities to develop cutting-edge solutions for global challenges.

Collaborations: Throughout his career, Claus Bregengaard has collaborated with multinational companies, innovative startups, and government agencies to bring his inventions to the market successfully.

Conclusion: Claus Bregengaard's passion for innovation and his dedication to creating a positive impact on society through his inventions make him a true pioneer in the world of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…